Ameritas Investment Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $244K | Sell |
1,252
-54
| -4% | -$11.2K | 0.01% | 1278 |
|
|
2026
Q1 | $293K | Sell |
1,306
-29
| -2% | -$7.23K | 0.01% | 1052 |
|
|
2025
Q4 | $322K | Hold |
1,335
| – | – | 0.01% | 991 |
|
|
2025
Q3 | $365K | Sell |
1,335
-49
| -4% | -$13.4K | 0.01% | 943 |
|
|
2025
Q2 | $357K | Sell |
1,384
-46
| -3% | -$11K | 0.01% | 976 |
|
|
2025
Q1 | $320K | Hold |
1,430
| – | – | 0.01% | 1007 |
|
|
2024
Q4 | $327K | Sell |
1,430
-58
| -4% | -$14K | 0.01% | 1031 |
|
|
2024
Q3 | $363K | Sell |
1,488
-58
| -4% | -$13K | 0.01% | 969 |
|
|
2024
Q2 | $296K | Sell |
1,546
-89
| -5% | -$18.1K | 0.01% | 1026 |
|
|
2024
Q1 | $324K | Hold |
1,635
| – | – | 0.01% | 998 |
|
|
2023
Q4 | $281K | Sell |
1,635
-108
| -6% | -$16.6K | 0.01% | 1068 |
|
|
2023
Q3 | $258K | Hold |
1,743
| – | – | 0.01% | 1031 |
|
|
2023
Q2 | $381K | Sell |
1,743
-88
| -5% | -$19.6K | 0.01% | 846 |
|
|
2023
Q1 | $401K | Hold |
1,831
| – | – | 0.02% | 824 |
|
|
2022
Q4 | $433K | Hold |
1,831
| – | – | 0.02% | 820 |
|
|
2022
Q3 | $399K | Hold |
1,831
| – | – | 0.02% | 814 |
|
|
2022
Q2 | $383K | Sell |
1,831
-79
| -4% | -$16.8K | 0.02% | 827 |
|
|
2022
Q1 | $463K | Hold |
1,910
| – | – | 0.02% | 822 |
|
|
2021
Q4 | $498K | Sell |
1,910
-78
| -4% | -$20.2K | 0.02% | 810 |
|
|
2021
Q3 | $524K | Hold |
1,988
| – | – | 0.02% | 782 |
|
|
2021
Q2 | $490K | Sell |
1,988
-120
| -6% | -$25.2K | 0.02% | 800 |
|
|
2021
Q1 | $409K | Hold |
2,108
| – | – | 0.02% | 848 |
|
|
2020
Q4 | $448K | Sell |
2,108
-167
| -7% | -$33.3K | 0.02% | 795 |
|
|
2020
Q3 | $390K | Hold |
2,275
| – | – | 0.02% | 784 |
|
|
2020
Q2 | $437K | Sell |
2,275
-124
| -5% | -$20.3K | 0.02% | 738 |
|
|
2020
Q1 | $353K | Hold |
2,399
| – | – | 0.02% | 727 |
|
|
2019
Q4 | $372K | Sell |
2,399
-120
| -5% | -$17.3K | 0.02% | 825 |
|
|
2019
Q3 | $340K | Hold |
2,519
| – | – | 0.02% | 841 |
|
|
2019
Q2 | $307K | Hold |
2,519
| – | – | 0.01% | 868 |
|
|
2019
Q1 | $262K | Hold |
2,519
| – | – | 0.01% | 913 |
|
|
2018
Q4 | $287K | Sell |
2,519
-202
| -7% | -$21.6K | 0.02% | 826 |
|
|
2018
Q3 | $314K | Hold |
2,721
| – | – | 0.01% | 862 |
|
|
2018
Q2 | $282K | Sell |
2,721
-213
| -7% | -$21.6K | 0.01% | 891 |
|
|
2018
Q1 | $289K | Sell |
2,934
-291
| -9% | -$27.5K | 0.01% | 911 |
|
|
2017
Q4 | $273K | Hold |
3,225
| – | – | 0.01% | 933 |
|
|
2017
Q3 | $250K | Sell |
3,225
-39,214
| -92% | -$3M | 0.01% | 944 |
|
|
2017
Q2 | $3.31M | Buy |
42,439
+681
| +2% | +$48.7K | 0.16% | 117 |
|
|
2017
Q1 | $3M | Sell |
41,758
-642
| -2% | -$44.4K | 0.15% | 131 |
|
|
2016
Q4 | $2.63M | Hold |
42,400
| – | – | 0.13% | 166 |
|
|
2016
Q3 | $2.75M | Buy |
42,400
+20,199
| +91% | +$1.34M | 0.15% | 135 |
|
|
2016
Q2 | $1.4M | Buy |
22,201
+1,072
| +5% | +$63.2K | 0.09% | 215 |
|
|
2016
Q1 | $1.22M | Hold |
21,129
| – | – | 0.08% | 240 |
|
|
2015
Q4 | $1.13M | Hold |
21,129
| – | – | 0.08% | 255 |
|
|
2015
Q3 | $1.08M | Hold |
21,129
| – | – | 0.08% | 263 |
|
|
2015
Q2 | $1.19M | Hold |
21,129
| – | – | 0.08% | 263 |
|
|
2015
Q1 | $1.52M | Buy |
21,129
+628
| +3% | +$40.8K | 0.1% | 222 |
|
|
2014
Q4 | $1.15M | Sell |
20,501
-242
| -1% | -$12.6K | 0.08% | 252 |
|
|
2014
Q3 | $1.02M | Sell |
20,743
-155
| -0.7% | -$7.89K | 0.07% | 282 |
|
|
2014
Q2 | $1.06M | Sell |
20,898
-18,420
| -47% | -$913K | 0.08% | 276 |
|
|
2014
Q1 | $1.76M | Sell |
39,318
-764
| -2% | -$34.3K | 0.14% | 184 |
|
|
2013
Q4 | $1.89M | Buy |
40,082
+17,567
| +78% | +$889K | 0.15% | 175 |
|
|
2013
Q3 | $1.19M | Buy |
+22,515
| New | +$1.09M | 0.11% | 230 |
|
Other funds holding RMD
Ameritas Investment Partners's RMD Position: Q2 2026 in Review
Ameritas Investment Partners reduced its ResMed (RMD) stake by 4.1% in Q2 2026, selling an estimated $11.2K and leaving 1,252 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #1278.
Ameritas Investment Partners first reported a position in RMD in Q3 2013 and has held it in 52 quarters since. The position peaked at $3.31M in Q2 2017. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Ameritas Investment Partners held 1,252 shares of ResMed worth $244K as of Q2 2026.
- Ameritas Investment Partners sold 54 ResMed shares in Q2 2026, an estimated $11.2K.
- ResMed made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1278 holding.
- Ameritas Investment Partners first reported a position in ResMed in Q3 2013 and has held it in 52 quarters since.
- Ameritas Investment Partners's ResMed position peaked at $3.31M in Q2 2017.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.